Coronary artery stents in the treatment of ischaemic heart disease

Meads C, Cummins C, Stevens A
Record ID 31999008501
English
Authors' objectives:

To examine the costs and benefits of routine stenting compared to percutaneous transluminal coronary angioplasty (PTCA) alone, medical treatment and coronary artery bypass grafting (CABG) for native coronary artery disease.

Authors' recommendations: The evidence from the meta analysis suggests that there are some small advantages in stent insertion compared to PTCA for patients groups with new lesions in native coronary arteries, in chronic coronary occlusion and following myocardial infarction. There is a decrease in the proportion of patients undergoing a repeat PTCA or target vessel revascularisation (PTCA or CABG) and a slightly better chance of no adverse event in the year following the initial stent insertion. The meta analysis shows that the stent group had a slightly better chance of being angina free at the end of the trials compared to the PTCA group. Benefits may be much greater for patients with chronic coronary occlusion. It is unknown whether this effect would be maintained for longer than one year following stent insertion.
Authors' methods: Systematic review
Details
Project Status: Completed
Year Published: 1998
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Coronary Artery Bypass
  • Costs and Cost Analysis
  • Myocardial Infarction
  • Stents
  • Coronary Disease
Contact
Organisation Name: West Midlands Health Technology Assessment Collaboration
Contact Address: Elaena Donald-Lopez, West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham B15 2TT Tel: +44 121 414 7450; Fax: +44 121 414 7878
Contact Name: louise.a.taylor@bham.ac.uk
Contact Email: louise.a.taylor@bham.ac.uk
Copyright: University of Birmingham
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.